— Know what they know.
Not Investment Advice

ACHL NASDAQ

Achilles Therapeutics plc
1W: +2.8% 1M: +7.2% 3M: +53.4% 1Y: +14.7% 3Y: -52.9%
$1.48
Last traded 2025-03-24 — delisted
NASDAQ · Healthcare · Biotechnology · $60.8M mcap · 20M float · 6.39% daily turnover · Short 31% of daily vol

No ESG data available for ACHL

ESG scores are derived from SEC filings (10-K, 10-Q) and may not be available for all companies.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms